Sara Willis, Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1350 Cedar Lake Rd, Pocatello, ID 83204 Phone: 208-201-2784 |
Patty J Ackerman, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 777 Hospital Way Bldg A, Suite 300, Pocatello, ID 83201 Phone: 208-239-3412 Fax: 208-239-3441 |
Tracy Gibson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 500 S 11th Ave, Suite 402, Pocatello, ID 83201 Phone: 208-239-3412 Fax: 208-239-3441 |
Mrs. Julia Lancaster Muckerman, CNM, MSN Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 777 Hospital Way, Suite 300, Pocatello, ID 83201 Phone: 208-232-6100 |
Jeanette Nicole Lamb, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1175 Call Place, Ste 100h, Pocatello, ID 83201 Phone: 208-261-4233 Fax: 833-471-4276 |
News Archive
Qualcomm Incorporated today announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global connected therapy management collaboration. Novartis will leverage Qualcomm Life's connectivity solutions to power its next-generation connected Breezhaler, the inhaler for its Chronic Obstructive Pulmonary Disease (COPD) portfolio.
Bellicum Pharmaceuticals, Inc. today announced the presentation of Phase I/II safety and efficacy data for BPX-101, a novel drug-activated dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in three separate posters at the 2011 Genitourinary Cancers Symposium held in Orlando, Florida on February 17 – 19, 2011.
FitLife Brands, Inc., an international provider of innovative and proprietary nutritional supplements for health conscious consumers marketed under the brand names NDS Nutrition Products™ (NDS), PMD®, SirenLabs® and CoreActive® today announced financial results for the first quarter ended March 31, 2014.
The first patients have been dosed in a multi-regional Phase IIB randomized, placebo-controlled clinical trial for the treatment of hepatitis B-associated liver cancer.
› Verified 2 days ago